Plant Phenotyping Market worth $268.1 million by 2023

The plant phenotyping market is estimated to be USD 158.2 million in 2018 and is projected to reach USD 268.1 million by 2023, at a CAGR of 11.14%. The market growth is driven by factors such as the growing demand for sustainable crop production using improved crop varieties and significant advancements in imaging sensors.

Different types of plant phenotyping equipment include conveyor-based/modular systems, bench-based systems, portable/handheld systems, and drones. Conveyor-based systems are mostly preferred by plant breeders as there is a high demand for high-throughput phenotyping systems. The use of drones is projected to grow in the future as they have high demand in countries with limited manpower and higher ease in the procurement of data.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236591018

Flexible and extendable computational tools are required to address the diversity of plant phenotyping problems. Thus, the demand for software tools is projected to grow at a higher CAGR during the forecast period as they help to measure and provide reliable data about plant traits in a non-destructive manner through image analysis, data acquisition, and system controls.

Europe accounted for the largest share of the plant phenotyping market in 2017; followed by North America and Asia Pacific. High emphasis on the funding of plant phenotyping experiments from governments and other organizations in Europe and North America has played a vital role in the growth of the market in these regions. Additionally, key players in the global market are located in the European region, which makes it the dominant market with effective phenotyping research and services over other regions.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of key companies such as LemnaTec (Germany), Delta-T Devices (UK), CropDesign – BASF SE (Germany), Heinz Walz (Germany), Phenospex (Netherlands), WPS (Netherlands), Photon Systems Instruments (Czech Republic), Qubit Systems (Canada), KeyGene (Netherlands), Rothamsted Research (UK), The Vienna Biocenter Core Facilities (Austria), and Phenomix (France).